CID Capital’s Private Equity Group makes majority investments in lower-middle-market companies with a strong history of consistent performance. Their focus is on companies that have the potential to grow significantly but have been constrained by lack of capital, operating systems, or management experience. CID provides the resources and capital to overcome these critical constraints.
| Company | Date | Round | Size | Participants |
| AxioMed Spine | 10/10 | Series D | $15M | 7 |
| EKOS Corporation | 3/06 | Series C | $26M | 9 |
| AGEIA Technologies | 10/05 | Series C | $27.5M | 7 |